Skip to content

Author

Ana Martínez

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products.

This review provides a structured overview of biologics and natural products in the ALS clinical pipeline, with particular emphasis on candidates that entered, advanced through, or completed clinical evaluation between 2022 and the end of 2025.

C. Huang, C. Sanchez-Santos, L. Martínez-González et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.